ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0A5R Calliditas Therapeutics Ab

0.00
0.00 (0.00%)

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 2016201720182019202020212022
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 000184.83M874k229.35M805.74M
Operating Income -56.52M-84.65M-133.2M-27.88M-382.22M-518.37M-398.87M
Pre Tax Income -56.91M-86.79M-132.05M-32.5M-436.15M-513.37M-409.42M
Net Income -56.91M-86.79M-132.05M-32.58M-433.49M-500.29M-412.27M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) -4.291-5.206-3.751-0.842-8.68-9.558-6.92
EBIT -56.52M-84.65M-133.2M-27.88M-382.22M-518.37M-398.87M
EBITDA -56.41M-84.6M-133.15M-26.06M-379.4M-483.94M-398.87M

Your Recent History

Delayed Upgrade Clock